The Biggest Number Behind “Food Noise” Comes From Asking People to Remember

The promise, and where it comes from

Ask any woman who has been on one of these drugs what changed first and a striking number will not say the scale. They will say the noise stopped — the running commentary about what is in the kitchen, what is left in the fridge, what she will eat later.

It is the most repeated claim in this category. It is also the least settled, and the gap between how confidently it is stated and how well it has been measured is worth understanding before you decide what to expect.

The study everyone quotes

The largest figure in circulation comes from the INFORM survey, published in 2026: 550 US adults taking injectable semaglutide for weight management, 86% of them women, mean age 53. They completed a five-item Food Noise Questionnaire scored out of 20¹.

Agreement with statements indicating food noise fell from 47–63% before to 15–20% after, consistently across treatment duration and BMI subgroups. Eighty-three percent reported satisfaction with treatment¹.

Those are large effects and they match what women describe. Now the part that rarely travels with the number.

The "before" score was collected afterwards. It is based on respondents' recollection of how they felt prior to starting¹ — asked of people who were already taking the drug, and by their own report already satisfied with it. Nobody measured them before they began. Human memory of a state you have since escaped is not a neutral instrument, and it tends to sharpen the contrast.

Two further things are stated in the paper's own declarations, and a reader deserves them. Four of the authors are employees of Novo Nordisk, which makes semaglutide; the market-research company that ran the panel was paid consulting fees by Novo Nordisk to perform the analysis; and no institutional review board approval or waiver was requested, on the basis that the survey did not meet the definition of research on human subjects¹.

None of that makes the finding false. Manufacturer-run surveys are normal and often informative. It does mean this is a satisfaction survey with a recalled baseline rather than a trial, and the authors say so themselves, closing with a call for prospective, longitudinal research¹.

The researchers who study the construct are not sure it is one

Running underneath is a more basic problem: nobody has established what food noise is.

A 2026 commentary in Appetite makes the case directly. The term entered scientific, clinical, commercial and public discourse very fast, dedicated measurement tools appeared, and yet limited evidence exists about its underlying mechanisms or whether it reflects a distinct phenomenon at all².

The authors ask whether food noise is its own thing or an overlapping dimension of processes that already had names — food cue reactivity, food preoccupation, cravings, intrusive food-related cognitions — and flag conceptual overlap between the new instruments and existing scales, with limited evidence on clinical utility².

That is not a small caveat. If the questionnaire measuring food noise overlaps heavily with older craving scales, then a large drop on it may be re-describing something already known rather than identifying a new effect.

And when a different instrument is used, the answer changes. In the CRAVE study, 28 adults starting semaglutide or tirzepatide were followed for 24 weeks with food records and a validated cravings inventory. Food cravings were unchanged overall, though people who started with the highest cravings saw the largest reductions⁵. Same drugs, different measure, different result.

What women actually said, unprompted

The strongest evidence that something real is happening is not a questionnaire at all.

A 2026 qualitative study in JAMA Network Open interviewed 30 people across 15 US states — 19 of them women, mean age 54 — who were taking or had taken these drugs. Researchers analyzed the transcripts without a predetermined framework, and the first theme to emerge was reduction in food noise, psychological hunger, or appetite³.

Nobody handed them the phrase. It came out of what they said.

The same study's other themes are worth carrying too, because they complicate the marketing version. Participants were clear these drugs are not a standalone weight-loss solution; they described a wide spectrum of adverse effects and a willingness to endure substantial ones; they reported stigma shaped by why they had been prescribed it; and they found information and clinical support essential but highly variable³. The authors' conclusion is that the medication functions as a facilitator of behavior change rather than a replacement for it.

When quiet is not the same as better

There is a group for whom this section matters more than the rest of the page.

A 2026 article in the International Journal of Eating Disorders argues that the same mechanisms that reduce appetite and food preoccupation may also reinforce restriction, avoidance of regular eating, compulsive weight control, and relapse in people who are vulnerable to those patterns. It notes that prescribing pathways often lack systematic eating disorder screening, multidisciplinary monitoring, or guidance on distinguishing appropriate appetite modulation from emerging eating disorder psychopathology⁴.

Its first recommended priority is routine eating disorder screening before and during treatment⁴. That it has to be recommended tells you it is not standard.

If food has been a fraught subject for you at any point, the absence of hunger is not automatically a good sign, and it is a reasonable thing to raise before it becomes a pattern. What the evidence says about GLP-1s and disordered eating covers that ground properly.

Where this sits on the evidence scale

The experience is well attested and the measurement is immature, and both can be true at once.

What is solid: women consistently report that intrusive food thoughts diminish, including in a qualitative study where the theme emerged from their own words rather than from a prompt. What is weaker: the headline numbers come from a manufacturer-run survey with a recalled baseline, the construct itself is contested in the research literature, and a study using food records over 24 weeks found cravings unchanged overall.

So expect relief, and hold it loosely. If the noise stops, that is real and it is worth something. If it does not stop for you, the data does not say you are doing it wrong — it says the effect has not been measured well enough for anyone to promise it to you in the first place.